AB1087 LONG-TERM EFFICACY OF GUSELKUMAB IN FATIGUE AND IDENTIFICATION OF EARLY TREATMENT TARGETS: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY CONDUCTED IN BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS

التفاصيل البيبلوغرافية
العنوان: AB1087 LONG-TERM EFFICACY OF GUSELKUMAB IN FATIGUE AND IDENTIFICATION OF EARLY TREATMENT TARGETS: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY CONDUCTED IN BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
المؤلفون: Gladman, D. D., Starr, M., Ranza, R., Bravo Perdomo, A. M., Strauss, M., Shawi, M., Han, C., Rampakakis, E., Andrew Östör, A., Mease, P. J.
المصدر: Scientific Abstracts
بيانات النشر: BMJ Publishing Group Ltd and European League Against Rheumatism
سنة النشر: 2023
نوع الوثيقة: conference object
اللغة: unknown
DOI: 10.1136/annrheumdis-2023-eular.1918
الإتاحة: https://doi.org/10.1136/annrheumdis-2023-eular.1918Test
رقم الانضمام: edsbas.F87EA335
قاعدة البيانات: BASE
الوصف
DOI:10.1136/annrheumdis-2023-eular.1918